HUMANA INC

Smith Paul John’s new Humana RSU grant shows top‑tier confidence in the company’s Medicare Advantage plans and tech rollouts, suggesting a bullish long‑term outlook.

John’s new 544‑unit Humana buy signals insider confidence in the company’s Medicare‑Advantage strategy and long‑term growth prospects.

Humana insider holdings remain steady, signaling long‑term confidence and a bullish outlook despite modest price dips.

Insightful analysis of Kurt Hilzinger’s RSU buys shows Humana’s Medicare growth and insider confidence—why investors are watching the stock closely.

Humana insider activity shows top leadership confidence amid a rally, suggesting steady growth prospects and a bullish outlook for investors.

Humana insider activity shows steady confidence: Shetty Sanjay K added 887 shares, sold 401, keeping 12,544 holdings, signalling long‑term belief in growth.

Insider buying fuels hope for Humana as shares slump 32.9% from the year’s high; steady purchases by CEO Shetty suggest undervaluation and growth potential.

Humana insider buying signals confidence in Medicare strategy, even amid recent price dips – a must‑watch for investors eyeing future upside.